Sumitomo Mitsui Trust Group, Inc.
Position in CNTN — Canton Strategic Holdings, Inc.
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in CNTN
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$2,381,106
New position
Shares Held
728,167
first reported quarter
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sumitomo Mitsui Trust Group, Inc. holds $1,209,271,805 across 38 Biotechnology names. CNTN ranks #21 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
614,448 | $274,375,609 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
273,669 | $211,447,616 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,054,294 | $107,357,404 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,417 | $104,031,152 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
3,825,585 | $91,163,690 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
1,853,875 | $88,188,833 | |
| 7 | INSM |
INSMED Inc
|
501,282 | $81,969,632 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,273,705 | $61,099,628 |
All Filings in CNTN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,381,106 | 728,167 | Shares | Defined | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||